Table 2 Univariate and multivariate analyses of variables related to HF.
Variables | Univariate analysis | Multivariate analysis | |||||
|---|---|---|---|---|---|---|---|
OR | 95%CI | P-value | OR | 95%CI | P-value | ||
Sex | Female | Reference | |||||
Male | 1.246 | [0.849,1.829] | 0.261 | ||||
Age | <65 | Reference | Reference | ||||
≥ 65 | 9.837 | [6.399,15.123] | <0.001 | 3.329 | [1.304,8.83] | 0.013 | |
BMI | <25 kg/m2 | Reference | Reference | ||||
≥ 25 kg/m2 | 3.84 | [2.596,5.680] | <0.001 | 3.616 | [1.48,9.199] | 0.005 | |
ASA | <3 | Reference | |||||
≥ 3 | 0.966 | [0.661,1.414] | 0.860 | ||||
Drinking history | No | Reference | Reference | ||||
Yes | 3.927 | [2.651,5.816] | <0.001 | 2.336 | [0.972,5.683] | 0.058 | |
Smoking history | No | Reference | Reference | ||||
Yes | 7.864 | [5.220,11.846] | <0.001 | 9.834 | [2.467,47.594] | 0.002 | |
Surgical history | No | Reference | |||||
Yes | 1.128 | [0.769,1.654] | 0.538 | ||||
Anemia | No | Reference | |||||
Yes | 1.118 | [0.734,1.704] | 0.603 | ||||
Hyperlipidemia | No | Reference | Reference | ||||
Yes | 6.539 | [4.360,9.807] | <0.001 | 4.906 | [2.043,12.286] | <0.001 | |
Hypertension | No | Reference | Reference | ||||
Yes | 7.415 | [4.920,11.175] | <0.001 | 5.565 | [2.307,14.306] | <0.001 | |
Diabetes | No | Reference | Reference | ||||
Yes | 5.325 | [3.575,7.933] | <0.001 | 10.564 | [4.197,29.318] | <0.001 | |
Preoperative tachycardia | No | Reference | Reference | ||||
Yes | 4.026 | [2.719,5.961] | <0.001 | 6.481 | [2.666,16.979] | <0.001 | |
COPD | No | Reference | Reference | ||||
Yes | 4.377 | [2.950,6.494] | <0.001 | 4.456 | [1.804,11.575] | 0.001 | |
CKD | No | Reference | |||||
Yes | 1.248 | [0.766,2.033] | 0.373 | ||||
T-stage | T1 ~ T2 | Reference | Reference | ||||
T3 ~ T4 | 4.036 | [2.688,6.061] | <0.001 | 2.496 | [0.963,6.551] | 0.060 | |
N-stage | N0 | Reference | Reference | ||||
N1 ~ N2 | 4.401 | [2.952,6.561] | <0.001 | 2.832 | [1.085,7.608] | 0.035 | |
Adjuvant Radiotherapy | No | Reference | |||||
Yes | 1.545 | [0.981,2.434] | 0.060 | ||||
Adjuvant Chemotherapy | No | Reference | |||||
Yes | 0.949 | [0.622,1.448] | 0.808 | ||||
Surgical procedure | Laparoscopic surgery | Reference | |||||
Open surgery | 0.781 | [0.534,1.143] | 0.203 | ||||
Emergency surgery | No | Reference | |||||
Yes | 0.991 | [0.656,1.497] | 0.965 | ||||
Lymph node dissection | <12 | Reference | |||||
≥ 12 | 0.771 | [0.505,1.178] | 0.230 | ||||
Surgery time | <270 min | Reference | Reference | ||||
≥ 270 min | 4.858 | [3.264,7.230] | <0.001 | 1.572 | [0.361,6.385] | 0.535 | |
Intraoperative bleeding | <100 ml | Reference | Reference | ||||
≥ 100 ml | 5.704 | [3.791,8.583] | <0.001 | 1.811 | [0.722,4.598] | 0.205 | |
Blood transfusion | No | Reference | Reference | ||||
Yes | 8.786 | [5.806,13.295] | <0.001 | 10.438 | [4.288,27.675] | <0.001 | |
Intraoperative tachycardia | No | Reference | Reference | ||||
Yes | 4.982 | [3.332,7.449] | <0.001 | 8.435 | [3.466,22.614] | <0.001 | |
Tumor number | <2 | Reference | |||||
≥ 2 | 1.081 | [0.672,1.742] | 0.747 | ||||
Tumor size | <5 cm | Reference | Reference | ||||
≥ 5 cm | 2.507 | [1.591,3.951] | <0.001 | 2.351 | [0.749,7.263] | 0.137 | |
CEA level | <5 ng/ml | Reference | |||||
≥ 5 ng/ml | 1.17 | [0.735,1.863] | 0.507 | ||||
CA19-9 level | <37 U/mL | Reference | |||||
≥ 37 U/mL | 0.728 | [0.449,1.182] | 0.199 | ||||
PCT level | <0.05 ng/ml | Reference | |||||
≥ 0.05 ng/ml | 1.148 | [0.773,1.704] | 0.494 | ||||
CRP level | <10 mg/l | Reference | Reference | ||||
≥ 10 mg/l | 4.396 | [2.952,6.546] | <0.001 | 3.556 | [1.473,9.105] | 0.006 | |
SAA level | <10 mg/l | Reference | |||||
≥ 10 mg/l | 0.986 | [0.674,1.441] | 0.940 | ||||
NLR | <3 | Reference | Reference | ||||
≥ 3 | 3.089 | [2.096,4.553] | <0.001 | 3.842 | [1.617,9.621] | 0.003 | |
ALB | ≥ 30 g/L | Reference | Reference | ||||
<30 g/L | 2.821 | [1.895,4.200] | <0.001 | 1.43 | [0.583,3.487] | 0.429 | |
NRS2002 score | <3 | Reference | |||||
≥ 3 | 0.786 | [0.506,1.222] | 0.286 | ||||
Disease duration | <6 months | Reference | |||||
≥ 6 months | 1.126 | [0.741,1.710] | 0.578 | ||||